摘要
目的观察N-乙酰半胱氨酸注射液(NAC)对胸外科肺叶切除术后患者的肺保护作用及可能机制。方法选取40例胸腔镜肺叶切除术的患者,随机分为实验(N-乙酰半胱氨酸,A组,下同)和对照(生理盐水,B组,下同)组,每组各20例。A组术后静脉滴注N-乙酰半胱氨酸(8g/次,qd),B组术后静脉滴注生理盐水(250mL/d);采集患者麻醉诱导前(T0),术后8h(T1),术后24h(T2),术后48h(T3)静脉血标本,采用酶联免疫吸附法(Elisa)测定血浆肿瘤坏死因子-α(TNF-α)、白细胞介素-6(IL-6)、超氧化物歧化酶(SOD)水平。结果 T0时间点,两组血浆TNF-α、IL-6、SOD浓度之间无显著差异(P> 0. 05);与T0比较,两组血浆TNF-α、IL-6浓度在T1-3明显上升,SOD浓度明显下降(P <0. 05),A组T1~3血浆TNF-α、IL-6浓度均明显低于B组(P <0. 05),SOD明显高于B组(P <0. 05)。结论 NAC在肺叶切除术后对肺脏具有一定的保护作用,其机制可能与NAC抑制炎症因子的表达和减轻氧化应激有关。
Objective To observe the protective effect of N-acetylcysteine injection( NAC) on lung in patients after thoracic lobectomy and to explore its possible mechanism. Methods 40 patients after thoracoscopic lobectomy were randomly divided into the experimental group( N-acetylcysteine,the group A) and the control group( normal saline,the group B). The group A received intravenous infusion of N-acetylcysteine( 8 g/times,qd),and the group B received intravenous infusion of normal saline( 250 mL/d). Their blood sample were collected at the time of before anesthesia induction( T0),8 h( T1),24 h( T2),and 48 h( T3) after operation. Plasma levels of tumor necrosis factor-α( TNF-α),interleukin-6( IL-6) and superoxide dismutase( SOD) were measured by enzyme-linked immunosorbent assay( Elisa). Results There was no significant difference in plasma TNF-α and IL-6 and SOD concentrations between the two groups at T0( P > 0. 05). Compared with T0,the concentrations of TNF-α and IL-6 at T1-3 and SOD decreased significantly in both groups( P < 0. 05). The concentrations of TNF-α and IL-6 at T1-3 were significantly lower than those in the group B( P < 0. 05). SOD was significantly higher than that in the group B( P < 0. 05). Conclusion NAC has a protective effect on lung after lobectomy,and its mechanism may be related to the inhibition of inflammatory factor expression by NAC and the reduction of oxidative stress.
引文
[1] DELLA ROCCA G,COCCIA C. Acute lung injury in thoracic surgery[J]. Curr Opin Anaesthesiol,2013,26(1):40-46.
[2] ABRAHAM E. Neutrophils and acute lung injury[J]. Crit Care Med,2003,31(S4):S195-S199.
[3]张笑天,郑晓瑛.氧化自由基清除剂超氧化物歧化酶与疾病[J].中国公共卫生,2014,30(10):1349-1352.
[4] PATRIARCA S,FURFARO A L,DOMENICOTTI C,et al. Supplementation with N-acetylcysteine and taurine failed to restore glutathione content in liver of streptozotocin-induced diabetics rats but protected from oxidative stress[J]. Biochim Biophys Acta,2005,1741(1/2):48-54.
[5] DUBE K M,DITCH K L,HILLS L. Use of Nebulized Heparin,Nebulized N-Acetylcysteine,and Nebulized Epoprostenol in a Patient With Smoke Inhalational Injury and Acute Respiratory Distress Syndrome[J]. J Pharm Pract,2017,30(6):663-667.
[6] BHAT P V,PANDAREESH M D,KHANUM F,et al. Cytotoxic effects of Ochratoxin A in Neuro-2a Cells:role of oxidative stress evidenced by N-acetylcysteine[J]. Front Microbiol,2016,7:1142-1153.
[7]江继鹏,程远驰,刘宝虎,等. N-乙酰半胱氨酸抑制急性脊髓损伤后炎症因子的作用研究[J].天津医药,2017,45(8):817-821.
[8] SAMUNI Y,GOLDSTEIN S,DEAN O M,et al. The chemistry and biological activities of N-acetylcysteine[J]. Biochim Biophys Acta,2013,1830(8):4117-4129.
[9] BAKER W L,ANGLADE M W,BAKER E L,et al. Use of N-acetylcysteine to reduce post-cardiothoracic surgery complications:a meta-analysis[J]. Eur J Cardiothorac Surg,2009,35(3):521-527.
[10] SADOWSKA A M,MANUEL-Y-KEENOY B,DE BACKER W A.Antioxidant and anti-inflammatory efficacy of NAC in the treatment of COPD:discordant in vitro and in vivo dose-effects:a review[J].Pulm Pharmacol Ther,2007,20(1):9-22.
[11] RAPADO-CASTRO M,DODD S,BUSH A I,et al. Cognitive effects of adjunctive N-acetyl cysteine in psychosis[J]. Psychol Med,2017,47(5):866-876.